Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;35(7):101915.
doi: 10.1016/j.ijgc.2025.101915. Epub 2025 May 3.

Prognostic value of tertiary lymphoid structures in molecular subgroups of endometrial carcinoma

Manohar Pradhan  1 , Wanja Kildal  2 , Ljiljana Vlatkovic  2 , Kari Anne R Tobin  2 , Kristina Lindemann  3 , Gunnar B Kristensen  4 , Andreas Kleppe  5 , Hanne A Askautrud  2
Affiliations
Free article

Prognostic value of tertiary lymphoid structures in molecular subgroups of endometrial carcinoma

Manohar Pradhan et al. Int J Gynecol Cancer. 2025 Jul.
Free article

Abstract

Tertiary lymphoid structures, lymphoid cell clusters formed in response to cancer or chronic disease, serve as a prognostic marker in multiple cancer types, including endometrial carcinoma. We assessed the prognostic significance of tertiary lymphoid structures, using the surrogate marker L1 cell adhesion molecule (L1CAM), in 1208 endometrial carcinoma patients in all stages, histological subtypes, and risk groups. Immunohistochemical evaluation of L1CAM in 1 tissue section from each patient revealed tertiary lymphoid structure-positivity in 287 of 1208 (23.8%) cases. In univariable analyses, patients with tertiary lymphoid structure-positive tumors had significantly longer time to recurrence (HR 0.61, p < .001) and cancer-specific survival (HR 0.53, p < .001) compared to patients with tumors without tertiary lymphoid structures. In multivariable analyses with standard clinical and pathological markers as well as modern molecular classification, the presence of tertiary lymphoid structures was an independent prognostic marker for time to recurrence (HR 0.63, p < .001) and cancer-specific survival (HR 0.54, p < .001). The presence of tertiary lymphoid structures was more frequent in POLE-mutated (59.4%) and mismatch repair deficient (32.3%) compared to p53-abnormal (15.8%) and no specific molecular profile (14.7%) tumors. In patients with p53-abnormal tumors, the presence of tertiary lymphoid structures was significantly associated with better outcomes for both time to recurrence (HR 0.51, p = .014) and cancer-specific survival (HR 0.52, p = .021) in multivariable analyses. These findings suggest that the evaluation of tertiary lymphoid structures by L1CAM may enhance prognostic precision in endometrial carcinoma.

Keywords: Endometrial Cancer; L1CAM; Molecular Classification; Prognosis; Tertiary Lymphoid Structure.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interests KL reports a relationship with Eisai Inc that includes: consulting or advisory and speaking and lecture fees. KL reports a relationship with AstraZeneca that includes: consulting or advisory and speaking and lecture fees. KL reports a relationship with Merck & Co Inc that includes: consulting or advisory and speaking and lecture fees. KL reports a relationship with Nycode that includes: consulting or advisory. KL reports a relationship with Karyopharm Therapeutics Inc that includes: consulting or advisory. KL reports a relationship with GSK that includes: consulting or advisory and speaking and lecture fees. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Substances

LinkOut - more resources